The estimated Net Worth of Ventures Fund V General Par... is at least $224 dollars as of 4 March 2019. Ventures Par owns over 933,333 units of Kaleido Biosciences Inc stock worth over $224 and over the last 6 years Ventures sold KLDO stock worth over $0.
Ventures has made over 1 trades of the Kaleido Biosciences Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently Ventures bought 933,333 units of KLDO stock worth $13,999,995 on 4 March 2019.
The largest trade Ventures's ever made was buying 933,333 units of Kaleido Biosciences Inc stock on 4 March 2019 worth over $13,999,995. On average, Ventures trades about 933,333 units every 0 days since 2019. As of 4 March 2019 Ventures still owns at least 2,244,305 units of Kaleido Biosciences Inc stock.
You can see the complete history of Ventures Par stock trades at the bottom of the page.
Over the last 6 years, insiders at Kaleido Biosciences Inc have traded over $0 worth of Kaleido Biosciences Inc stock and bought 3,273,186 units worth $32,952,342 . The most active insiders traders include Ventures Fund Iv General Pa..., Joshua T Brumm, eVentures Fund V General Par.... On average, Kaleido Biosciences Inc executives and independent directors trade stock every 119 days with the average trade being worth of $55. The most recent stock trade was executed by Daniel L Menichella on 8 February 2021, trading 20,000 units of KLDO stock currently worth $230,000.
the next breakthrough microbiome company from flagship venturelabs – the innovation foundry of flagship ventures – is coming.
Kaleido Biosciences Inc executives and other stock owners filed with the SEC include: